Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
51.58B | 50.30B | 46.19B | 43.45B | 39.28B | 38.27B | Gross Profit |
10.37B | 10.01B | 9.40B | 8.68B | 7.58B | 7.29B | EBIT |
6.07B | 5.86B | 5.39B | 4.92B | 4.20B | 3.86B | EBITDA |
6.55B | 6.33B | 5.83B | 5.48B | 4.46B | 4.35B | Net Income Common Stockholders |
4.39B | 4.29B | 4.09B | 3.47B | 2.77B | 2.67B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
18.03B | 18.81B | 15.35B | 15.18B | 12.38B | 11.49B | Total Assets |
44.92B | 44.14B | 40.66B | 36.81B | 32.66B | 30.52B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-18.03B | -18.81B | -15.35B | -15.18B | -12.38B | -11.49B | Total Liabilities |
10.09B | 10.96B | 10.78B | 10.30B | 9.04B | 9.14B | Stockholders Equity |
34.83B | 33.17B | 29.88B | 26.52B | 23.62B | 21.37B |
Cash Flow | Free Cash Flow | ||||
3.13B | 4.65B | 1.55B | 3.47B | 1.63B | 3.70B | Operating Cash Flow |
3.45B | 5.05B | 2.00B | 3.73B | 2.00B | 3.89B | Investing Cash Flow |
6.80B | -8.70B | -1.01B | -344.00M | -583.00M | -306.00M | Financing Cash Flow |
-1.41B | -894.00M | -818.00M | -607.00M | -520.00M | -492.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥5.10T | 28.56 | 8.97% | 0.75% | -1.55% | 17.24% | |
75 Outperform | ¥2.37T | 20.53 | 8.55% | 1.73% | 3.60% | 6.61% | |
74 Outperform | ¥1.32T | 29.33 | 1.68% | 24.10% | 11.27% | ||
70 Outperform | ¥31.18B | 6.22 | 2.57% | 22.72% | -11.06% | ||
68 Neutral | ¥37.80B | 10.32 | 3.35% | 4.53% | -6.57% | ||
66 Neutral | ¥1.11T | 19.67 | 16.17% | 2.57% | 15.49% | 18.42% | |
61 Neutral | $11.29B | 10.07 | -7.05% | 2.96% | 7.47% | -10.75% |